While colorectal cancer polyps often have no symptoms—especially in the early stages—there are some warning signs to be on ...

The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...

As we grapple with AI’s place on our roads, in our classrooms and alongside us in the workplace, there’s one realm in which ...

Many people are simply unaware of the existence of the FIT test or underestimate its importance in colorectal cancer ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

Blood in your bowels could be a sign of several potentially serious health conditions, and understanding the cause is crucial ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $29.9 billion by 2032, ...

Commonly used fecal immunochemical tests vary in their performance, which has implications for the benefits and ...

The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an ...

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission ...